BRCA1 and breast carcinoma: Despite the fact that false positive and false negative BRCA1/2 PGV results are rare and multi-gene panel testing is commonly used to screen for other breast cancer-predisposing PGVs, patients must be advised that not identifying a BRCA1/2 or other PGV does not mean that the patient’s risk for developing breast cancer is no different than the general population.